PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
PharmaCyte Biotech, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.34+0.00 (+0.53%)
Close on Oct 19, 2026
- Market cap
- $3.67M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
7.1%
1M of 11M shares
Institutional holders
28
2 new, 5 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $128.50K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Waqas Khatri | 774,100 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Mitchell P. Kopin | 695,715 | 9.99% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PMCB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 283,381 | 2.64% | $218.20K | −76,166 | 0.00% |
| Geode Capital Management, LLC | 124,247 | 1.16% | $95.68K | −71,413 | 0.00% |
| Vanguard Capital Management LLC | 56,778 | 0.53% | $43.72K | +5,311 | 0.00% |
| Susquehanna International Group, Llp | 44,853 | 0.42% | $34.54K | New | 0.00% |
| Renaissance Technologies LLC | 37,987 | 0.35% | $29.25K | −18,513 | 0.00% |
| XTX Topco Ltd | 34,180 | 0.32% | $26.32K | −18,182 | 0.00% |
| Northern Trust Corp | 32,624 | 0.30% | $25.12K | −2,977 | 0.00% |
| Jane Street Group, LLC | 30,064 | 0.28% | $23.15K | +18,534 | 0.00% |
| Schonfeld Strategic Advisors LLC | 26,926 | 0.25% | $20.73K | −83 | 0.00% |
| Vanguard Fiduciary Trust Co | 23,452 | 0.22% | $18.06K | – | 0.00% |
| Equitec Proprietary Markets, LLC | 22,227 | 0.21% | $17.12K | – | 0.00% |
| Commonwealth Equity Services, LLC | 20,255 | 0.19% | $15.60K | +9,942 | 0.00% |
| Hrt Financial LP | 15,451 | 0.14% | $11 | −9,290 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,888 | 0.05% | $3.76K | −1 | 0.00% |
| UBS Group AG | 4,142 | 0.04% | $3.19K | −377 | 0.00% |
| Group One Trading, L.P. | 500 | 0.00% | $385 | −1,285 | 0.00% |
| Osaic Holdings, Inc. | 303 | 0.00% | $232 | +1 | 0.00% |
| Covestor Ltd | 275 | 0.00% | $0 | – | 0.00% |
| Barclays PLC | 192 | 0.00% | $148 | New | 0.00% |
| Sachetta, LLC | 14 | 0.00% | $11 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 28 | 1M | 7.1% | 2 / 6 | 10 / 5 | 0M | 0M |
| Q1 2026 | 32 | 1M | 9.0% | 9 / 6 | 7 / 4 | 0M | 0M |
| Q4 2025 | 28 | 1M | 9.2% | 7 / 5 | 7 / 1 | 1M | 0M |
| Q3 2025 | 23 | 0M | 4.0% | 6 / 3 | 4 / 6 | 0M | 0M |
| Q2 2025 | 23 | 1M | 5.4% | 2 / 6 | 3 / 3 | 0M | 0M |
| Q1 2025 | 24 | 1M | 5.3% | 4 / 4 | 8 / 1 | 0M | 0M |
| Q4 2024 | 21 | 1M | 5.6% | 1 / 2 | 10 / 5 | 0M | 0M |
| Q3 2024 | 26 | 1M | 7.7% | 2 / 3 | 10 / 3 | 0M | 0M |
| Q2 2024 | 28 | 1M | 9.6% | 3 / 10 | 9 / 3 | 0M | 0M |
| Q1 2024 | 29 | 1M | 9.1% | 1 / 9 | 9 / 4 | 0M | 0M |
| Q4 2023 | 32 | 1M | 10.1% | 5 / 11 | 8 / 3 | 0M | 0M |
| Q3 2023 | 31 | 1M | 10.6% | 4 / 8 | 9 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PMCB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 101,568 | 0.95% | $84.75K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 56,778 | 0.53% | $43.72K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 26,211 | 0.24% | $21.87K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 15,256 | 0.14% | $12.73K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 12,896 | 0.12% | $10.76K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joshua Silverman | CEO and President, Director | 466,250 | 4.34% | Jan 7, 2026 |
| Wayne Remell Walker | Director | 37,500 | 0.35% | Jul 17, 2026 |
| Robert Weinstein | Director | 41,250 | 0.38% | Jul 17, 2026 |
| Michael M. Abecassis | Director | 23,092 | 0.22% | Jul 17, 2026 |
| Jonathan Schechter | Director | 192,500 | 1.79% | Jul 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jonathan Schechter Director | Jan 7, 2026 | Buy | +20,000 | $0.84 | $16.80K | 192,500 |
| Joshua Silverman CEO and President, Director | Jan 7, 2026 | Buy | +40,000 | $0.83 | $33.20K | 416,250 |
| Jonathan Schechter Director | Jan 6, 2026 | Buy | +20,000 | $0.79 | $15.80K | 172,500 |
| Joshua Silverman CEO and President, Director | Jan 6, 2026 | Buy | +30,000 | $0.79 | $23.70K | 376,250 |
| Jonathan Schechter Director | Jan 5, 2026 | Buy | +20,000 | $0.78 | $15.60K | 152,500 |
| Joshua Silverman CEO and President, Director | Jan 5, 2026 | Buy | +30,000 | $0.78 | $23.40K | 346,250 |
| Wayne Remell Walker Director | Dec 12, 2025 | Award | +37,500 | – | – | 37,500 |
| Wayne Remell Walker Director | Dec 12, 2025 | Tax withholding | −16,875 | $1.02 | $17.21K | 20,625 |
| Joshua Silverman CEO and President, Director | Dec 12, 2025 | Tax withholding | −258,750 | $1.02 | $263.93K | 316,250 |
| Joshua Silverman CEO and President, Director | Dec 12, 2025 | Award | +575,000 | – | – | 575,000 |
| Robert Weinstein Director | Dec 12, 2025 | Tax withholding | −33,750 | $1.02 | $34.43K | 41,250 |
| Robert Weinstein Director | Dec 12, 2025 | Award | +75,000 | – | – | 75,000 |
| Michael M. Abecassis Director | Dec 12, 2025 | Tax withholding | −16,875 | $1.02 | $17.21K | 22,292 |
| Michael M. Abecassis Director | Dec 12, 2025 | Award | +37,500 | – | – | 39,167 |
| Jonathan Schechter Director | Dec 12, 2025 | Award | +150,000 | – | – | 200,000 |
| Jonathan Schechter Director | Dec 12, 2025 | Tax withholding | −67,500 | $1.02 | $68.85K | 132,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.